Abstract:Ines Matia-Garcia, 1 Eduardo Vadillo, 2 Rosana Pelayo, 3 José F Muñoz-Valle, 4 Mariel García-Chagollán, 4 Jaqueline Loaeza-Loaeza, 1 Amalia Vences-Velázquez, 1 Lorenzo Salgado-Goytia, 1 Samuel García-Arellano, 4 Isela Parra-Rojas 1 1 Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, México; 2 Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, Centro Médico Nacional, Instituto Mexicano del Seguro Social, Ciudad de México, México; 3 Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Atlixco, Puebla, México; 4 Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, México Correspondence: Isela Parra-Rojas Laboratorio de Investigación en Obesidad y Diabetes, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Avenida Lázaro Cárdenas S/N, Ciudad Universitaria, Chilpancingo, Guerrero, 39090, México Tel +52 7474719310 Email Purpose: We aim to identify Th1 and Th2 cell clusters in young subjects, including their clinical and metabolic characteristics and the Th1/Th2 balance. Patients and Methods: A total of 100 participants were included. The frequencies of Th1 and Th2 cells in peripheral blood were determined by flow cytometry. Serum C-reactive protein was measured using a turbidimetric assay, and insulin levels were quantified with an enzyme-linked immunosorbent assay. Circulating cytokine levels were analyzed using a multiplex system. Results: A cluster analysis was performed to determine the Th1/Th2 balance in a group of young people, and 3 clusters were formed with the following characteristics: 1) subjects with a higher prevalence of hyperglycemia (38%), dyslipidemia (38– 75%), and insulin resistance (50%), as well as a higher percentage of Th1 cells and Th1/Th2 ratio, including elevated IFN-ɣ levels; 2) subjects with a lower prevalence of hyperglycemia (23%) and insulin resistance (15.4%), but a higher prevalence of dyslipidemia (8– 85%) with a predominance of Th2 cells, and lower Th1/Th2 ratio; 3) subjects with a lower prevalence of hyperglycemia (6%), insulin resistance (41%), and dyslipidemia (10– 63%), as well as a balance of Th1 and Th2 cells and lower Th1/Th2 ratio, including low IFN-ɣ levels. Positive correlations between Th1 cells with IFN-γ, IL-12, and IL-1β and between Th2 cells with IFN-γ, IL-2, and IL-4 were found (p < 0.05). A significant increase in Th1 cells was observed in the presence of hyperglycemia and high LDL-C levels, as well as increased Th2 cells in the absence of abdominal obesity and high blood pressure, including low HDL-C levels. The Th1/Th2 ratio was higher in the group with high cardiometabolic risk (p = 0.03). Conclusion: Th1/Th2 balance is related to metabolic abnormalities that may occur in young population, and thus the timely identification of different phenotypes may help predict an increased cardiometabolic risk. Keywords: Th1 cells, Th2 cells, hyperglycemia, dyslipidemias, IFN-ɣ levels Chronic low-grade systemic inflammation is an essential component of metabolic diseases, such as insulin resistance (IR), type 2 diabetes mellitus (T2DM), hypertension, metabolic syndrome (MetS), nonalcoholic fatty liver disease (NAFLD), and cardiovascular disease (CVD). In this sense, obesity is considered the main link between inflammation and these comorbidities. 1,2 Chronic low-grade inflammation is characterized by circulating elevated levels of acute-phase proteins and cytokines, including C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin 1β (IL-1β), interleukin 6 (IL-6), and the increased infiltration of immune cells, namely macrophages and T lymphocytes in insulin-dependent tissue. 3,4 Several epidemiological studies have shown elevated levels of inflammatory biomarkers, for instance, CRP, and IL-6 in T2DM, interleukin 12 (IL-12) in T2DM, and a mixed Th1 and Th2 serum cytokine profile in subjects with MetS. 5–7 Similarly, in another study, a mixed Th1 and Th2 serum cytokine profile in T2DM, while subjects with T2DM-coronary artery disease showed an increase in Th1 cytokines and a reduction in Th2 cytokines, indicating that in addition to proinflammatory cytokines, Th2 cytokines could play an important role in inflammation, IR, T2DM, and MetS. 8 These high concentrations of inflammatory biomarkers reflect the activation of both innate and adaptive immune systems in response to metabolic changes that occur in obesity and its comorbidities. 9 The a -Abstract Truncated-

Serum Levels of IL-1 RA Increase with Obesity and Type 2 Diabetes in Relation to Adipose Tissue Dysfunction and are Reduced After Bariatric Surgery in Parallel to Adiposity

Increased Levels of Interleukin-36 in Obesity and Type 2 Diabetes Fuel Adipose Tissue Inflammation by Inducing Its Own Expression and Release by Adipocytes and Macrophages

Interleukin-17A Gene Expression in Morbidly Obese Women

Interleukin-16 is increased in obesity and alters adipogenesis and inflammation in vitro

Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation

Increased Interleukin-32 Levels in Obesity Promote Adipose Tissue Inflammation and Extracellular Matrix Remodeling: Effect of Weight Loss

Increased expression of IL-1β in adipose tissue in obesity influences the development of colon cancer by promoting inflammation

Inflammatory Cytokine Profiles in Visceral and Subcutaneous Adipose Tissues of Obese Patients Undergoing Bariatric Surgery Reveal Lack of Correlation With Obesity or Diabetes

Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls

Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance

The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction

The Roles of IL-6, IL-10, and IL-1RA in Obesity and Insulin Resistance in African-Americans.

Links Between Adipose Tissue Gene Expression of Gut Leakage Markers, Circulating Levels, Anthropometrics, and Diet in Patients with Coronary Artery Disease

Serum Fatty Acids and Inflammatory Patterns in Severe Obesity: A Preliminary Investigation in Women

Zinc Transporter ZnT1 mRNA Expression Is Negatively Associated with Leptin Serum Concentrations but Is not Associated with Insulin Resistance or Inflammatory Markers in Visceral Adipose Tissue

Dynamics of Serum Inflammatory Markers and Adipokines in Patients: Implications for Monitoring Abnormal Body Weight: Preliminary Research

Obesity-associated Inflammation Induces Microrna-155 Expression in Adipocytes and Adipose Tissue: Outcome on Adipocyte Function

Th1/Th2 Balance in Young Subjects: Relationship with Cytokine Levels and Metabolic Profile

Incremental Elevations in TNFα and IL6 in the Human Colon and Procancerous Changes in the Mucosal Transcriptome Accompany Adiposity

Reappraisal of Adipose Tissue Inflammation in Obesity

Linking adipose tissue eosinophils, IL-4, and leptin in human obesity and insulin resistance